Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2015-03-16 Transaction in Own Shar…
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares 2015
Transaction in Own Shares Classification · 99% confidence The document explicitly details transactions made by Novozymes to purchase its own B shares under a previously announced stock buyback program. It provides a table showing the number of shares purchased, average price, and total transaction value for specific dates (March 9 to March 13, 2015), culminating in an accumulated total of 1,000,000 shares. This activity directly corresponds to the definition of 'Transaction in Own Shares' (share repurchase). The filing code for this activity is POS.
2015-03-16 English
Transaction in Own Shares 2015
Transaction in Own Shares Classification · 100% confidence The document text is very short (394 characters) and describes a specific transaction: Novozymes buying back 1,000,000 shares under a previously announced share repurchase program. The final line, 'Læs hele meddelelsen i pdf format' (Read the full announcement in pdf format), strongly suggests this is a brief announcement about a transaction rather than the full regulatory filing detailing the transaction. This aligns best with the 'Transaction in Own Shares' category (POS), which covers share repurchase programs. Although it could potentially be RNS (Regulatory Filings), POS is more specific to the content described (share buybacks). Given the brevity and the call to read the full PDF, it is a notification of the transaction.
2015-03-16 Danish
Transaction in Own Shares 2015
Transaction in Own Shares Classification · 99% confidence The document explicitly details transactions made by Novozymes to repurchase its own shares under a previously announced stock buyback program. It provides specific dates, number of shares bought, average prices, and total transaction values. This directly corresponds to the definition of 'Transaction in Own Shares' (POS), which covers share repurchases.
2015-03-09 English
Transaction in Own Shares 2015
Transaction in Own Shares Classification · 100% confidence The document text explicitly states that Novozymes has purchased an accumulated number of shares under a 'stock buyback program' initiated on February 2, 2015. This action directly relates to the company acquiring its own shares. The classification 'Transaction in Own Shares' (POS) is the most appropriate fit for reporting share repurchases. Although the text mentions reading the full announcement in PDF format, the core content is the transaction update itself, making POS more specific than RPA or RNS.
2015-03-09 English
Transaction in Own Shares 2015
Transaction in Own Shares Classification · 100% confidence The document text is very short (265 characters) and explicitly states that Novozymes bought back shares under a previously announced program ('aktietilbagekøbsprogram'). This describes a transaction involving the company's own shares. The final sentence, 'Læs hele meddelelsen i pdf format' (Read the full announcement in pdf format), suggests this is a brief notification rather than the full detailed report. The most specific category for reporting the company buying back its own shares is 'Transaction in Own Shares' (POS). Since it's a brief announcement pointing to a PDF, it could potentially be RPA, but the content is a direct report of a transaction, making POS the primary fit, even if it's a short notice about it.
2015-03-02 Danish
Transaction in Own Shares 2015
Transaction in Own Shares Classification · 99% confidence The document explicitly details transactions where Novozymes purchased its own B shares under a stock buyback program, providing specific dates, quantities, prices, and accumulated totals. This directly corresponds to the definition of a 'Transaction in Own Shares' (share repurchase). The filing code for this activity is POS.
2015-03-02 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.